Chronic vasculitis and polyneuropathy due to infection with Bartonella henselae

B Stockmeyer 1, C Schoerner, P Frangou, T Moriabadi, D Heuss, T Harrer Case study: Bartonella henselae linked to chronic ulcers, polyneuropathy, and Raynaud’s. Highlights diagnostic challenges, treatment success with erythromycin, and importance of considering B. henselae in patients with peripheral neuropathy. https://pubmed.ncbi.nlm.nih.gov/17401716/ This is something I see quite frequently in my patient population–peripheral neuropathy with acrocyanosis, positive serology for Bartonella…

Read More

Microbes and Mental Illness: Past, Present and Future

by Robert C. Bransfield, Charlotte Mao and Rosalie Greenberg Healthcare 2024, 12(1), 83; https://doi.org/10.3390/healthcare12010083 Submission received: 31 October 2023 / Revised: 30 November 2023 / Accepted: 6 December 2023 / Published: 29 December 2023 This review explores the complex relationship between microbes and mental illness, covering historical perspectives, definitions, and associated infectious agents. It highlights the evolution of mental illness etiology from supernatural beliefs…

Read More

Biomarker-Based Analysis of Pain in Patients with Tick-Borne Infections before and after Antibiotic Treatment

Tick-borne illnesses (TBIs), especially those caused by Borrelia, are increasingly prevalent worldwide. These diseases progress through stages of initial localization, early spread, and late dissemination. The final stage often leads to post-treatment Lyme disease syndrome (PTLDS) or chronic Lyme disease (CLD), characterized by persistent and non-specific multisystem symptoms affecting multiple systems, lasting over six months…

Read More

Tafenoquine for Babesiosis

Tafenoquine is a relatively new medication approved or the treatment of malaria (FDA approved 2018) that has recently been repurposed as a treatment for Babesiosis, a relatively common tick borne infection in parts of the United States. Because Babesia is a common co-infection with Lyme disease, clinicians have begun using tafenoquine in patients with “treatment…

Read More